1-NA-PP1 has been researched along with N-[2-[4-(2-oxo-3H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-2-naphthalenecarboxamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baffoe, J; Cho, H; Curry, V; Keyes, R; Kulkarni, A; Quang, P; Stieglitz, K; Török, B; Zhou, W | 1 |
1 other study(ies) available for 1-NA-PP1 and N-[2-[4-(2-oxo-3H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-2-naphthalenecarboxamide
Article | Year |
---|---|
1,3-disubstituted-4-aminopyrazolo [3, 4-d] pyrimidines, a new class of potent inhibitors for phospholipase D.
Topics: Binding Sites; Catalytic Domain; Drug Design; Enzyme Inhibitors; HEK293 Cells; Humans; Kinetics; Micelles; Molecular Dynamics Simulation; Phospholipase D; Protein Binding; Pyrazoles; Pyrimidines; Structure-Activity Relationship | 2014 |